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Abstract
Background: Newer technologies in neonatal ventilation such as combining volume guarantee with other modes of ventilation
could reduce some complications of artificial ventilation by reducing the duration of ventilation and oxygen needs and fluctuations.
Retinopathy of prematurity (ROP) is a multifactorial problem mainly affecting preterm infants with different risk factors. Although
gestational age (GA) is the main risk factor for ROP, oxygen saturation and fluctuations, arterial pressure of carbon dioxide, and
some other parameters of ventilation such as ventilation duration have great impacts on ROP incidence and severity.
Methods: One hundred and twelve infants with birthweight (BW) under 2000 g or GA under 36 weeks that needed artificial ven-
tilation after admission to the neonatal intensive care unit were randomly assigned into two groups. In the first group, neonates
underwent synchronized intermittent mandatory ventilation (SIMV), pressure support ventilation (PSV), or SIMV + PSV with volume
guarantee (VG); and in the second group, neonates received ventilation without VG mode. All of the survived infants had ophthal-
mologic examination at the proper age by a retinal subspecialist to find the different stages of ROP.
Results: Mean duration of ventilation was reduced using VG mode from 74.08± 47.99 to 47.91± 30.47 hours (P < 0.05). The oxygen
requirement was less in the ones underwent VG modes and the peak fractional inspired oxygen (FiO2) was higher in infants receiving
SIMV + PSV without VG compared to that of infants ventilated with VG mode (52.8± 18.4 vs. 40.3± 13.0, respectively). The difference
between highest and lowest FiO2 was more in the group ventilated without VG (∆FiO2 = 9.52 in the group I and 18.30 in the group
II, P < 0.05). Fluctuation of arterial pressure of carbon dioxide (PaCO2) was less prominent in the VG group as compared to the ones
ventilated without VG and the mean difference between maximum and minimum PaCO2 was 7.16 in the group I and 13.36 in the
group II (P < 0.05). Only three infants were diagnosed with ROP in the group I (with VG mode) in comparison with eight infants
in the group II (odds ratio (OR) = 3.25, 95% confidence interval (CI): 1.13 - 9.36). Severe ROP needing treatment was diagnosed in one
infant in the group I vs. four infants in the group II (OR = 3, 95%CI: 0.63 - 14.23).
Conclusions: ROP incidence in preterm infants could be reduced using VG mode of ventilation, since it is a safer ventilation mode
in neonates due to reduction in the mean duration of ventilation, peak FiO2 requirement, and PaCO2 fluctuation.
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1. Background
Retinopathy of prematurity (ROP) is defined as an ar-
rest of retinal vascular development with neuronal abnor-
malities in the preterm infant (1). Several risk factors are
associated with its occurrence and progression that are di-
vided into fixed and modifiable ones. Gestational age (GA),
low and very low birthweight (BW), and intrauterine expo-
sure to adverse factors are the well identified risk factors at
birth (1). Although being small for gestational age is a ma-
jor risk factor, some studies just proved its impact on older
infants (> 29 week of GA) (2, 3).
Profound impact of controlling modifiable risk fac-
tors made them more noteworthy nowadays. Some of
the most significant risk factors reported in preterm in-
fants are the duration of mechanical ventilation and oxy-
gen supplement, surfactant therapy (4), preeclampsia, 1-
minute Apgar score, severity of respiratory distress syn-
drome, hypotension, septicemia, intraventricular hemor-
rhage, chronic lung disease (5, 6), prolonged and late post-
natal steroids treatment (7), number of blood transfusions,
and acidosis (8).
High oxygen saturations (SpO2) and fluctuations in
oxygen concentrations due to different disease processes
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during the first few weeks of life may have a positive rela-
tionship with the incidence of ROP (9).
Since safe level of oxygen saturation differs with post-
menstrual age and stage of ROP, no fixed SpO2 range is rec-
ommended so far (9). Lower SpO2 level in early days of life
could roughly have a preventive effect on ROP; though it in-
creased death rates in several studies (10). Although avoid-
ance of alteration between hypoxia and hyperoxia seems
to be one of the desirable methods to decrease ROP, the
benefits should be balanced against the risk of mortality
and other morbidities such as cerebral palsy (11, 12).
Volume guarantee (VG) is a modern mode of ventila-
tion for neonates. It is a time-cycled and pressure-limited
mode of ventilation. In this method, peak inspiratory pres-
sure changes according to the measured expired tidal vol-
ume in each breath. Maintaining the expired tidal volume
to the level set by the operator is the end result of the pro-
cess (13). The benefit of using this mode of ventilation is the
maintenance of a set tidal volume as a result of the com-
bination between volume-controlled and pressure-limited
ventilation (14).
The effects of VG are recently studied with various aims
including duration of ventilation, total need of oxygen
supplementation, weaning from the ventilation (15), and
neonatal morbidities and mortality (16); the latter one was
more considerable. Guven et al., demonstrated lower in-
cidence of bronchopulmonary dysplasia, intraventricular
hemorrhage, and ROP in the subjects ventilated by VG
mode compared to the ones received SIMV (10). However,
to the best of authors’ knowledge, no study so far investi-
gated the incidence of ROP after VG ventilation specifically
by controlling confounding factors.
There are different guidelines for ROP screening, which
are different in cutoff ranges, between 30 and 35 weeks of
gestational age (GA) and 1500 to 2000 g of BW (17, 18). In
Iran, it is recommended to examine all infants under 2000
g or less than 34 weeks of GA.
ROP has different stages; stages 3 and 4 need imme-
diate management decisions, but in lower stages, close
follow-up is recommended (19, 20).
2. Methods
The current study was conducted in the neonatal inten-
sive care unit (NICU) of HRH. The study was approved by
the Ethics Committee of the Iran University of Medical Sci-
ences. Its layout was randomized, controlled trial and the
sample size was calculated 112.
Preterm infants under 2000 g or less than 36 weeks of
GA admitted to NICU that needed ventilation in the first
week of life were included in the present trial. The exclu-
sion criteria were major anomalies that needed surgery,
eye anomalies, and five-minute Apgar scores less than 5.
Infants that died before discharge were excluded as well.
After obtaining written consents from the parents, the
subjects were randomly divided into two corresponding
groups, each consisting of 56 infants. The subjects were al-
located to the study groups by random number method.
The study was performed from May 2013 to December 2015.
It was a single-blind study as the nurses and physicians
were informed about the ventilation mode. Neonates ad-
mitted to NICU after birth in this hospital or admitted
from other hospitals in the first week of life with GA less
than 36 weeks and respiratory distress were examined by
the physician and included in the study if not showing
the exclusion criteria. Neonates were intubated and ven-
tilated according to the fixed protocols of NICU (i.e. show-
ing apnea requiring mask and bag ventilation, requiring
more than 50% fractional inspired oxygen (FiO2) with nasal
continuous positive airway pressure applied at 6 cmH2O,
and abnormal arterial blood gas); some of them were in-
tubated after failure of nasal continuous positive airway
pressure. Surfactant administration was similar in both
groups based on NICU guidelines. In group I, the ventila-
tion mode was SIMV, pressure support ventilation (PSV), or
changing between these modes according to their venti-
lation needs with VG. The targeted volume in VG was 4 - 6
mL/kg. The group II received SIMV, PSV, or SIMV + PSV with-
out VG. Other therapeutic procedures in the two groups
were principally similar.
Both groups were ventilated by FabianTM ventilators
(Acutronic Medical Systems, Switzerland).
All infants were monitored with Spacelab patient mon-
itors and their oxygen saturation (SaO2) was recorded ev-
ery one hour and if they needed extra oxygen or resusci-
tation. FiO2 was recorded at the beginning of each shift
and if it was changed more than 5% at the shift. Arterial
pressure of carbon dioxide (PaCO2) was measured by arte-
rial blood gases as ordered by the physician and at least
once a day till they were ventilated. The required informa-
tion was gathered on admission using questionnaires in-
cluding several sections such as general information (gen-
der, GA, BW, Apgar score at birth, place of birth), venti-
lation specifications (mode of ventilation, peak FiO2, and
minimum FiO2), general outcomes (ventilation duration,
maximum arterial pressure of oxygen (PaO2), minimum
PaO2, maximum PaCO2, minimum PaCO2, pneumothorax,
and death), and ROP (occurrence of ROP and severe ROP,
which requires treatment) after ophthalmic examination
in the NICU or ophthalmology clinic in HRH if they were
discharged from hospital at the screening time.
To screen the neonates for ROP, indirect ophthal-
moscopy was undertaken based on regular guidelines.
Meeting at least one of these criteria was sufficient to be
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examined: GA < 36 weeks or BW < 2000 g and being venti-
lated mechanically. A retinal subspecialist with great expe-
rience in ROP screened the neonates during the study.
Data were analyzed with SPSS software version 23
(IBM® Corporation, USA) using chi-square test, indepen-
dent samples t-test, ANOVA, Pearson correlation, and linear
regression. The 95% confidence interval (CI) was calculated
if needed. P < 0.05 was considered the level of significance.
3. Results
Twenty-seven female (48.2%) and 29 male (51.8%) infants
with an average (± standard deviation) GA of 31.12 ± 2.04
weeks were enrolled in the group I; four infants died be-
fore eye examination (7%). There were 30 female (53.6%) and
26 male (46.4%) subjects with an average GA of 31.14 ± 2.31
weeks in the group II (P = 0.22); three infants died in this
group (5%, P = 0.8). From discharged infants, six subjects
from the group I (13%) and eight from the group II (17%) did
not refer for their eye examinations (P = 0.45, ns).
The average BW in the two groups was 1371.2 ± 326.2
and 1358.1261.6 g, respectively (P = 0.24).
Peak FiO2 and minimum FiO2 results are summarized
in Table 1.
Table 1. Comparison Between FiO2 Peak and FiO2 Minimum in the Two Modes of
Ventilation
Mode of Ventilation N Mean ± SD P Value
FiO2 peak < 0.05
SIMV, PSV 45 52.83 ± 18.42
SIMV + VG/PSV+ VG 46 40.39 ± 13.08
FiO2 minimum < 0.05
SIMV, PSV 45 34.53 ± 12.68
SIMV + VG/PSV+ VG 46 30.87 ± 8.86
∆FiO2 < 0.05
SIMV, PSV 45 18.30
SIMV + VG/PSV+ VG 46 9.52
Ventilation duration, maximum PaO2, minimum PaO2,
maximum PaCO2, minimum PaCO2, pneumothorax, and
death were compared between the two groups. VG mode
of ventilation had considerable effects on the studied out-
comes as shown in Table 2.
Pneumothorax, as the most important side effect of
ventilation, and death, as the main indicator of outcome,
were compared. The developing pneumothorax was more
possible if the patient was not ventilated by controlled vol-
umes. Nonetheless, there was no difference in the death
rate among neonates ventilated differently (Table 3).
Table 2. Outcomes of the Two Ventilation Modes
Mode of Ventilation N Mean ± SD P Value
Ventilation duration, h < 0.05
SIMV, PSV 45 84.08 ± 47.99
SIMV + VG/PSV+ VG 46 47.91 ± 30.40
PaCO2 maximum, mmHg < 0.05
SIMV, PSV 45 50.96 ± 9.22
SIMV + VG/PSV+ VG 46 46.17 ± 6.08
PaCO2 minimum, mmHg < 0.05
SIMV, PSV 45 37.60 ± 3.85
SIMV + VG/PSV+ VG 46 39.01 ± 2.23
PaO2 maximum, mmHg < 0.05
SIMV, PSV 45 92.25 ± 13.39
SIMV + VG/PSV+ VG 46 96.25 ± 7.86
PaO2 minimum, mmHg
SIMV, PSV 45 64.67 ± 13.37 0.29
SIMV + VG/PSV+ VG 46 66.05 ± 14.63
O2 dependency duration, d < 0.05
SIMV, PSV 45 7.39 ± 4.02
SIMV + VG/PSV+ VG 46 5.19 ± 2.49
Since many studies revealed contribution of blood gas
fluctuations with ROP (5, 6), in the current study, there was
more oscillation of such variables among those who devel-
oped ROP eventually (Table 4). PaCO2 and PaO2 fluctuations
were less prominent in the VG group as compared to the
ones received ventilation without VG and it contributed to
ROP incidence (Table 4).
The current trial mainly aimed to compare probable
preventive effect of SIMV + VG/PSV + VG on ROP incidence.
The two variables here were the development of ROP and
rate of severe ROP, which needed further ophthalmologic
treatment. Since 14 infants did not refer for eye examina-
tion (six in the group I and eight in the group II), 91 in-
fants were examined in several sessions by the same oph-
thalmologist. Overall, 11 infants showed different stages of
ROP (12%) and there was a significant difference between
the two groups (6% in infants ventilated with VG vs. 17%
in the ones ventilated without VG, P = 0.01). Odds ratio
(OR) for the development of ROP in patients received SIMV
+ VG/PSV + VG was 3.25 (95% CI: 1.13 - 9.36) whereas it was 0.83
in the corresponding group (95% CI: 0.71 - 0.97).
Similar preventive effects were observed in higher
stages of ROP, which needed treatment. The relative OR was
3.00 (95% CI: 0.63 - 14.23) for the SIMV + VG/PSV + VG group
and 0.93 (95% CI: 0.84 - 1.03) for the SIMV/PSV group (Table
5).
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Table 3. Odds Ratio of the Two Modes of Ventilation for Pneumothorax and Death
Mode of Ventilation OR




Yes 12 3 4 1.19 13.4
No 44 53 0.83 0.71 0.97
Death
Yes 3 4 1.75 0.54 5.65
No 53 52 0.94 0.83 1.07
Table 4. Blood Gas Changes in Analogous Groups of Developing ROP and Ventilation Type
Mean Difference Between Maximum and
Minimum PaCO2
P Value Mean Difference Between Maximum and
Minimum PaO2
P Value
ROP < 0.05 < 0.05
Yes 21.12 19.3
No 8.78 24





Table 5. OR of ROP and ROP Treatment After Two Ventilation Modes
Mode of Ventilation OR




Yes 8 3 3.25 1.13 9.36
No 37 43 0.83 0.71 0.97
ROP treatment
Yes 4 1 3 0.63 14.23
No 41 45 0.93 1.04 1.83
Therefore, it could be concluded that SIMV + VG/PSV +
VG in comparison with SIMV/PSV played a preventive role
in the incidence of ROP and its higher stages.
4. Discussion
Since many studies showed the effect of several fixed
factors on the incidence of ROP (2, 3); the primary goal of
the current study was to eliminate those factors between
the two groups by randomization and show the main ef-
fect of oxygen fluctuation, high oxygen level, and PaCO2 on
ROP.
Ventilating infants with less oxygen fluctuation in the
delivered tidal volume could protect the immature lungs
from hypo- or hyperventilation. The most significant ad-
vantage of VG is that in the face of rapidly changing lung
compliance, the actual tidal volume delivered to the pa-
tient circuit remains constant. This theoretically avoids
the situations of under distension and consequent alve-
olar hypoventilation, or over distension and lung injury.
Cheema et al., reported lower peak inspiratory pressure
and mean arterial pressure in the patients ventilated with
VG (11). Reduced time of ventilation was concluded as
an advantage of volume control (VC) versus time-cycled
pressure-limited (TCPL) methods by Sinha (12), Singh (13)
and Duman (14). These ventilation parameters have indi-
rect effect on ROP.
Herein, both minimum FiO2 and peak FiO2 were lower
in the VG group. Furthermore, total duration of mechan-
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ical ventilation and O2 dependency were lower in this
group. A recent trial by Cheema et al., in a stratified analysis
revealed that infants with GA > 25 weeks had significantly
less hypocarbia when VG was used (11) and it was found that
both hypo- and hypercarbia could be lessened with VG.
Although Guven et al., reported no difference in the air
leak between VG and SIMV ventilation modes (10), however,
pneumothorax was less frequent in VG mode of ventilation
in other studies (7, 8, 21) and the impact of VG on the in-
cidence of pneumothorax and mortality rate is still con-
troversial. Herein, pneumothorax proved to be less likely
in the VG group. A well-organized Cochrane review con-
cluded lower mortality after receiving ventilation with VG
(7), while Guven et al., found no significant decrease in
death rate after volume-controlled ventilation (10). Never-
theless, no differences could be observed between the sur-
vival rates of the two groups.
The main goal of the current study was to find the
impacts of ventilation type on ROP incidence and sever-
ity. Based on the current study, ROP incidence and sever-
ity were lessened by VG modes of ventilation as compared
to other modes without VG. It was tried to lessen the con-
founding factors between the two groups. This contribu-
tion with ROP, as a well-known comorbidity of prematurity,
was investigated by few studies before (7, 12). The strength
of the current study was gathering sufficient sample size
and dividing them into standard corresponding groups;
therefore, the results were thought to be more reliable. OR
of developing ROP was higher among the subjects venti-
lated without VG (OR = 3.25; 95%CI: 1.13 - 9.36), and those
with higher stages of ROP (requiring treatment) (OR = 3;
95%CI: 0.63 - 14.23). The limitation of the study was that the
invasive and non-invasive methods of ventilation were not
compared, and there were 14 missing data (15%).
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